Cargando...
Advances in preclinical approaches to Chagas disease drug discovery
INTRODUCTION: Chagas disease affects 8–10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unme...
Gardado en:
| Publicado en: | Expert Opin Drug Discov |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779130/ https://ncbi.nlm.nih.gov/pubmed/31411084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1652593 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|